Ready-Made immune cells tested to fight tough blood cancers
Disease control
Recruiting now
This early-stage study is testing a new type of treatment called MT-401-OTS, which uses specially prepared immune cells from healthy donors to fight cancer. It is for adults aged 65+ with certain types of relapsed acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) wh…
Phase: PHASE1 • Sponsor: Marker Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC